Director, Translational Science Lead
Renal, Inflammation and Fibrosis and Neurodegeneration
Translational Sciences (TS), within Respiratory, Immunology and Inflammation Research Unit (RIIRU) therapy area is accountable for end-to-end disease area translational science to inform therapy area and program level biomarker strategies (from preclinical to launch) to increase the probability of success from preclinical to clinical transitions and enable earlier and higher confidence asset related decisions. This includes generation of foundational data as well as disease biomarker development and validation that allow timely deployment of tools/biomarkers to support Proof of Mechanism (PoM), signs of clinical efficacy, Proof of Concept (PoC), and pairing Mechanisms of Action (MoAs) with patient subtypes to predict responder populations.

Key Responsibilities:
Disease Biomarker Strategy Development and Delivery:

• Partner with the Clinical Teams,...